Pharmacokinetics and Safety of Ceftobiprole in Neonates and Infants up to 3 Months Treated With Systemic Antibiotics
Clinical trial NCT02527681 · TERMINATED
Trial details
- NCT number
- NCT02527681
- Sponsor
- Basilea Pharmaceutica
- Status
- TERMINATED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2016-11-22
- Primary completion
- 2020-02-25
- Enrollment
- 15
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.